Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome

Clinical trial NCT00513578 · UNKNOWN

Trial details

NCT number: NCT00513578
Sponsor: The Vaccine Company
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2007-01-01
Primary completion: 2009-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.